SRT3 logo

Sartorius Stock Price

Symbol: XTRA:SRT3Market Cap: €11.5bCategory: Pharmaceuticals & Biotech

SRT3 Share Price Performance

€179.70
-63.00 (-25.96%)
42.0% undervalued intrinsic discount
€310.00
Fair Value
€179.70
-63.00 (-25.96%)
42.0% undervalued intrinsic discount
€310.00
Fair Value
Price €179.70
AnalystHighTarget €310.00
AnalystConsensusTarget €257.25
AnalystLowTarget €191.20

SRT3 Community Narratives

AN
AnalystHighTarget
AnalystHighTarget·Updated
Fair Value €310.00 42.0% undervalued intrinsic discount

Cell And Gene Therapies Will Expand Secular Bioproduction

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget·Updated
Fair Value €257.25 30.1% undervalued intrinsic discount

Advanced Biologic Adoption Will Expand Global Reach

0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget·Updated
Fair Value €191.20 6.0% undervalued intrinsic discount

Rising Tariffs, Regulatory Hurdles And Cost Pressures Will Squeeze Margins

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative

SRT3 Community Fair Values

Recent SRT3 News & Updates

No updates

Sartorius Aktiengesellschaft Key Details

€3.5b

Revenue

€1.9b

Cost of Revenue

€1.6b

Gross Profit

€1.5b

Other Expenses

€104.1m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 16, 2025
Earnings per share (EPS)
1.51
Gross Margin
45.76%
Net Profit Margin
3.00%
Debt/Equity Ratio
117.2%

Sartorius Aktiengesellschaft Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About SRT3

Founded
1870
Employees
13685
CEO
Michael Grosse
WebsiteView website
www.sartorius.com

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, and support and services; live-cell imaging and analysis software; contract manufacturing and integration; OEM membranes and devices, weigh cells, and data analytics; connectivity, and pipetting and dispensing products; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and surface plasmon resonance and process filtration products. The company offers water purification systems; lab data and fleet management software; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, weights and weight sets, paint mixing solutions, and weighing accessories; and bioprocess consulting and engineering, biologics testing, cell culture media, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

German Market Performance

  • 7 Days: 0.4%
  • 3 Months: -4.3%
  • 1 Year: 21.6%
  • Year to Date: 4.8%
The Communication Services sector gained 13% while the market remained flat over the last week. More promisingly, the market is up 22% over the past year. As for the next few years, earnings are expected to grow by 17% per annum. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading